About Chemo Mouthpiece
Chemo Mouthpiece is a company based in Closter (United States) founded in 2017 by David Yoskowitz.. Chemo Mouthpiece has raised $15.9 million across 3 funding rounds. The company has 12 employees as of December 31, 2024. Chemo Mouthpiece offers products and services including Chemo Mouthpiece Device and Patient Kit. Chemo Mouthpiece operates in a competitive market with competitors including Protip Medical, ENT Biotech Solutions, APrevent, OTT Medical and Surgimed, among others.
- Headquarter Closter, United States
- Employees 12 as on 31 Dec, 2024
- Founders David Yoskowitz
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Chemo Mouthpiece. Llc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.9 M (USD)
in 3 rounds
-
Latest Funding Round
$900 K (USD), Series A
Nov 05, 2024
-
Investors
-
Employee Count
12
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Chemo Mouthpiece
Chemo Mouthpiece offers a comprehensive portfolio of products and services, including Chemo Mouthpiece Device and Patient Kit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Cools mouth to reduce chemotherapy-induced oral mucositis pain.
Includes devices and tools for at-home oral cryotherapy use.
Unlock access to complete
Unlock access to complete
Funding Insights of Chemo Mouthpiece
Chemo Mouthpiece has successfully raised a total of $15.9M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $900 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $900,000
-
First Round
First Round
(22 Feb 2024)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Series A - Chemo Mouthpiece | Valuation |
investors |
|
| Sep, 2024 | Amount | Series A - Chemo Mouthpiece | Valuation |
investors |
|
| Feb, 2024 | Amount | Series A - Chemo Mouthpiece | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Chemo Mouthpiece
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Chemo Mouthpiece
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chemo Mouthpiece Comparisons
Competitors of Chemo Mouthpiece
Chemo Mouthpiece operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Protip Medical, ENT Biotech Solutions, APrevent, OTT Medical and Surgimed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable devices for larynx surgery are developed to reduce complications.
|
|
| domain | founded_year | HQ Location |
A disposable, single-use tool that cuts, cauterizes and removes tissue during tonsil and adenoid surgery
|
|
| domain | founded_year | HQ Location |
-
|
|
| domain | founded_year | HQ Location |
Offers professional architectural services for homeowners and commercial developers worldwide.
|
|
| domain | founded_year | HQ Location |
Develops innovative technologies for vocal cord nerve monitoring.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Chemo Mouthpiece
Frequently Asked Questions about Chemo Mouthpiece
When was Chemo Mouthpiece founded?
Chemo Mouthpiece was founded in 2017 and raised its 1st funding round 7 years after it was founded.
Where is Chemo Mouthpiece located?
Chemo Mouthpiece is headquartered in Closter, United States. It is registered at Closter, New Jersey, United States.
Who is the current CEO of Chemo Mouthpiece?
David Yoskowitz is the current CEO of Chemo Mouthpiece. They have also founded this company.
Is Chemo Mouthpiece a funded company?
Chemo Mouthpiece is a funded company, having raised a total of $15.9M across 3 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Feb 22, 2024.
How many employees does Chemo Mouthpiece have?
As of Dec 31, 2024, the latest employee count at Chemo Mouthpiece is 12.
What does Chemo Mouthpiece do?
Chemo Mouthpiece was founded in 2017 and is headquartered in Closter, United States. A medical device known as the Chemo Mouthpiece is developed by the company to deliver cryotherapy across the entire oral cavity. This device is intended for patients receiving chemotherapy, where it addresses oral mucositis as a frequent side effect. Operations focus on the healthcare sector, specifically oncology support through targeted cooling technology.
Who are the top competitors of Chemo Mouthpiece?
Chemo Mouthpiece's top competitors include Protip Medical, ENT Biotech Solutions and APrevent.
What products or services does Chemo Mouthpiece offer?
Chemo Mouthpiece offers Chemo Mouthpiece Device and Patient Kit.